🔎 Trials Near Me

መነሻ › ኖን-ስማል ሴል የሳንባ ካንሰር › ካሊፎርኒያ › San Diego

በSan Diego፣ CA ለኖን-ስማል ሴል የሳንባ ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች

ለኖን-ስማል ሴል የሳንባ ካንሰር የሚደረጉ 48 ጥናቶች በSan Diego እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2/3
  • UC San Diego Health - Moores Cancer Center /ID# 278836, La Jolla · 11 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT07155187

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Kaiser Permanente-San Diego Zion, San Diego
  • UC San Diego Moores Cancer Center, La Jolla · 11 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT04267848

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla · 11 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06465069

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • University of San Diego Moores Cancer Center, La Jolla · 11 ማይል ርቀት
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT04585750

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • UC San Diego Moores Cancer Center, La Jolla · 11 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06498635

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • University of California San Diego Moores Cancer Center, San Diego
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06625775

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • ALX Center 9, La Jolla · 11 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT07085091

A Study of PHN-012 in Patients With Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • PHN-012-001 Site, San Diego
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT07127874

A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • University of California at San Diego, La Jolla · 11 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT05498428

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • UC San Diego McGrath Outpatient Pavilion - Hillcrest, San Diego
  • UC San Diego Medical Center - Hillcrest, San Diego
  • UCSD Medical Center - Rancho Bernardo, San Diego
  • እና 3 ተጨማሪ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT07144280

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • University of California San Diego, La Jolla · 11 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT04981119

A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Moores Cancer Center at UC San Diego Health, La Jolla · 11 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06667908

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • University of California San Diego Health, La Jolla · 11 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06667076

Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Scripps Clinic Torrey Pines (Scripps Cancer Center), La Jolla · 11 ማይል ርቀት
  • Scripps Green Hospital, La Jolla · 11 ማይል ርቀት
  • Scripps Shiley Pavilion, La Jolla · 11 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07227298

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Kaiser Permanente San Diego Mission Road, San Diego
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT06890598

Pan-tumor MRD Study

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Medical Oncology Associates of San Diego (MOASD), San Diego
  • Medical Oncology Associates of San Diego, San Diego
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT06605404

Intratumoral N17350 in Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Scripps Clinic Torrey Pines - La Jolla, San Diego
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT07339176

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2/3
  • University Of California - San Diego Moores Cancer Center, La Jolla · 11 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT06712316

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Clinical Study Site, San Diego
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ18 ሴፕቴ 2026 · NCT06767514

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • University of California, San Diego, La Jolla · 11 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ14 ሴፕቴ 2026 · NCT05059444

A Phase 1/1b Study of IAM1363 in HER2 Cancers

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • UCSD Moores Cancer Center, La Jolla · 11 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ9 ሴፕቴ 2026 · NCT06253871

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla · 11 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ሴፕቴ 2026 · NCT06400472

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Research Site, San Diego
  • Research Site, La Jolla · 11 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ሴፕቴ 2026 · NCT07291037

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • University of California - San Diego Moores Cancer Center, La Jolla · 11 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT06343402

Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Sharp Memorial Hospital ( Site 9544), San Diego
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT06422143

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • UC San Diego Moores Cancer Center, La Jolla · 11 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ሴፕቴ 2026 · NCT07216105

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • University of California San Diego, Moores Cancer Center, San Diego
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ሴፕቴ 2026 · NCT04913285

Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Research Site, San Diego
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ26 ኦገስ 2026 · NCT06350097

Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Kaiser Permanente San Diego Mission Road, San Diego
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ26 ኦገስ 2026 · NCT07288177

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • UC San Diego Medical Center - Hillcrest, San Diego
  • California Protons Cancer Therapy Center, San Diego
  • UC San Diego Moores Cancer Center, La Jolla · 11 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ኦገስ 2026 · NCT06500481

A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • UC San Diego Moores Cancer Center, La Jolla · 11 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦገስ 2026 · NCT06706076

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • University of California, San Diego; Moores Cancer Center, San Diego
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ኦገስ 2026 · NCT05579366

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • University of California, San Diego Moores Cancer Center, San Diego
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ጁን 2026 · NCT06162221

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • UCSD Moores Cancer Center, La Jolla · 11 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ12 ጁን 2026 · NCT06051695

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • UC San Diego Moores Cancer Center, La Jolla · 11 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ጁን 2026 · NCT05642572

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • University of California San Diego Moores Cancer Center, San Diego
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ጁን 2026 · NCT06917079

A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Research Site, San Diego
  • Research Site, La Jolla · 11 ማይል ርቀት
እድሜ ከ18 እስከ 130 · ሁሉም ጾታዎች · የተሻሻለው በ14 ሜይ 2026 · NCT06417814

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • UC San Diego Moores Cancer Center, La Jolla · 11 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ6 ሜይ 2026 · NCT06116682

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

ተሳታዮችን በመፈለግ ላይደረጃ 2/3
  • Kaiser Permanente-San Diego Zion, San Diego
  • UC San Diego Moores Cancer Center, La Jolla · 11 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ሜይ 2026 · NCT06616584

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • UC San Diego Moores Cancer Center, La Jolla · 11 ማይል ርቀት
18 Minutes · ሁሉም ጾታዎች · የተሻሻለው በ5 ሜይ 2026 · NCT06031688

A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • University of California San Diego Moores Cancer Center, La Jolla · 11 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ኤፕሪ 2026 · NCT06010329

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • University of California San Diego (UC San Diego) Health - Jacobs Medical Center - Moores Cancer Center, La Jolla · 11 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ18 ማርች 2026 · NCT06244771

A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Research Site, La Jolla · 11 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ማርች 2026 · NCT06956690

EZH2 Inhibitor, Tulmimetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • VA San Diego Healthcare System, San Diego, CA, San Diego
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ27 ጃንዩ 2026 · NCT05467748

Retifanlimab and Ruxolitinib In Solid Malignancies

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • University of California, San Diego Moores Cancer Center, La Jolla · 11 ማይል ርቀት
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ13 ጃንዩ 2026 · NCT07219576

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Massive Bio SYNERGY-AI site, La Jolla · 11 ማይል ርቀት
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ28 ኦክቶ 2025 · NCT03452774

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • UCSD Moores Cancer Center, La Jolla · 11 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ9 ሴፕቴ 2025 · NCT06682793

Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • UC San Diego Moores Cancer Center, La Jolla · 11 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ፌብሩ 2024 · NCT04282044

በሌሎች ከተሞች ለኖን-ስማል ሴል የሳንባ ካንሰር የሚደረጉ ጥናቶች

በSan Diego ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።